Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Some epilepsy drugs can cause reproductive and cosmetic side effects in women and affect pregnancy, but most women still have healthy babies.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

Genetic manipulations that extend lifespan in mice may not work as effectively in humans.

Caffeine penetrates human skin in lab tests similarly to real-life conditions, but actual skin use is still essential for accurate results.

Hydroxychloroquine may help delay skin damage in lupus patients.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Men with untreated male pattern hair loss continue to lose hair over a 5-year period.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

Gene differences found in hair follicles linked to male baldness.

PRP treatments for hair loss need standard protocols to be reliable.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

Higher energy, longer exposure, and pulse irradiation improve hair density in androgenetic alopecia treatment.

Inconsistent platelet counts in PRP are due to varying blood volumes, preparation methods, and analyzer types.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Topical finasteride/minoxidil is effective but not better than oral finasteride for hair loss.

Dutasteride 0.5 mg is safe and effective for long-term use in Korean men with hair loss.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Dutasteride is safe and effective long-term for male hair loss.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Rare genetic variants in 125 genes are linked to male-pattern hair loss.

Finasteride users have higher odds of certain health issues and lower odds of specific lifestyle factors compared to nonusers.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.